Navigation Links
New Standard for Incision Care Established by Vomaris Innovations' New Product

CHANDLER, Ariz., Sept. 4, 2013 /PRNewswire/ -- Vomaris Innovations, Inc., a regenerative medical device company specializing in microcurrent field generating technologies for the wound care market, announced a new product that is raising the bar for surgical wound care.

Featuring the company's flagship wireless microcurrent technology, Procellera HELIX Post-Op™ addresses the primary healing issues of surgical incisions, offering superior antimicrobial protection and its unique microcurrents that result in reduced healing time.  Recent published data has shown Procellera to have superior antimicrobial protection against real clinical wound isolates.

Applied directly over sutures, staples, steri-strips and liquid skin adhesives, Procellera HELIX Post-Op™ is an "all in one" dressing that can be worn for up to 7 days post surgery. The unique shape combats the localized forces that increase the likelihood of dehiscence and increases patient comfort and mobility with its unique stress-shielding design.

"As a joint replacement surgeon, infection control and wound healing are top priorities," said Jimmy Chow, M.D., a hip and knee specialist at Hedley Orthopaedic Institute.  "(Procellera) HELIX Post-Op™ is a cost-effective solution that is also easier on my hospital and clinical staff.  My wounds look great and my hospital, staff and patients are happy."

George Swartz M.D., Orthopedic Surgeon at the Phoenix VA Medical Center commented further, "The Procellera HELIX (Post-Op)™ conforms to the knee, is less bulky, and stays applied to the incision better than any product I have used before."

"It's always a win for a company when its technology can set a new standard," said Michael Nagel, Vomaris® President and CEO.  "Procellera HELIX Post-Op™ addresses the market need with superior antimicrobial protection, ease of use, cost efficiency, and most importantly — an improved patient experience."

About Vomaris Innovations, Inc. Vomaris Innovations, Inc., based in Chandler, Arizona, is a leading edge regenerative medical device company specializing in microcurrent field generating technologies for the wound care market. Its product, Procellera®, is the world's first self-contained antimicrobial wound dressing with microbatteries at its surface. Procellera® is a unique device due to its inherent design with microcurrent technology. Procellera® is indicated for over-the-counter (OTC) and professional (Rx) uses. Randomized clinical trials are in process looking at other possible wound healing benefits for the use of Procellera®.

For more information, visit or call 480.921.4948.

SOURCE Vomaris Innovations, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Takeda EXAMINE Cardiovascular Safety Outcomes Trial of Alogliptin Met Primary Endpoint of Non-Inferiority Compared to Placebo in Addition to Standard of Care Showing No Increase in Cardiovascular Risk in Type 2 Diabetes Patients at High-Risk for Car
2. SMI Again Raises the Standard of Mobile Eye Tracking
3. Sanofi Pasteurs Fluzone High-Dose Vaccine Significantly More Effective Than Standard Dose Fluzone Vaccine in Preventing Influenza in Adults 65 Years of Age and Older
4. Ethio-American Doctors On Track To Introduce International Standard Medical Center To Ethiopia
5. Enhance Perioperative & Anesthesia Consulting Develops Indices To Measure Hospital Operating Room Efficiency, Costs, Other Key Standards
6. BioCision Announces Two New U.S. Patents for Thermo-Conductive Products that Standardize Sample Handling in Laboratory Research
7. Frost & Sullivan: Standardized Regulations Crucial for Growth in Global Dimensional Metrology Market for Medical Devices
8. Ranbaxy kündigt Verbesserungen bei Geschäftsstandards und Qualitätssicherungsinitiativen an
9. Ranbaxy Announces Improved Business Standards and Quality Assurance Initiatives
10. New Compendium Offers Freely Available Testing Standards to Help Ensure the Quality of Herbal Ingredients Used in Traditional Medicines
11. U-Care Line: Setting the Standard of Care for Smaller Anatomy
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... adds "Global Repaglinide Industry ... Report on China Repaglinide Market, 2010-2019" ... data and information to its online ... . --> ...
(Date:11/26/2015)... 2015 Research and Markets ( ... "2016 Future Horizons and Growth Strategies in the ... Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities" ... --> --> This new 247-page ... therapeutic drug monitoring market, including emerging tests, technologies, ...
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... announced the addition of the  "2016 ... the European Cell Surface Marker Testing ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology:
(Date:11/28/2015)... (PRWEB) , ... November 28, 2015 , ... Safe storage ... creativity of two inventors, one from Lakewood, New Jersey and the other from Bradley ... the patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often ...
(Date:11/28/2015)... ... ... a.m. EST until 11:59 p.m. EST, customers will be racing the clock ... $80 or more to free gifts with purchases, there will be a new sale available ... for skin care and cosmetic needs, customers will save on already discounted prices. , Top ...
(Date:11/27/2015)... ... ... There is only one major question facing all law firms in the ... has not been an easy question to answer. Especially when the senior partners and ... don’t share the same discipline around working long hours. , In addition to ...
(Date:11/27/2015)... ... November 27, 2015 , ... According to an article ... University of Toronto and the University of British Columbia suggested that laws requiring bicyclists ... The article explains that part of the reason for the controversial conclusion is that, ...
(Date:11/27/2015)... ... November 27, 2015 , ... The rapid speed at which ... age, more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions ... overworked. The forgotten part of this equation: 80 percent of medical care occurs ...
Breaking Medicine News(10 mins):